Brain mapping can be conceived as a higher form of neuroimaging, producing brain images supplemented by the result of additional (imaging or non-imaging) data processing or analysis, such as measures of behavior in brain regions. The increasing integration of advanced technology in the healthcare facilities for better treatment owing to an increasing market size of brain imaging instruments. Furthermore, the rising prevalence of brain disorders coupled with the increasing efforts to understand the brain complexities for future disease treatment catalyzing the market growth of brain mapping instruments. For instance, as per the CDC, every year, more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes.
The
brain mapping instruments market is expected to grow at a steady rate of around
13% owing to rising brain diseases and the adoption of advanced diagnostic
equipment. Major companies in the market that offer Brain Mapping
Instruments are Medtronic, General Electric Company, Koninklijke Philips
N.V., Siemens Healthcare Private Limited, and Advanced Brain Monitoring Inc.
Unlock The Table of Content, And Request a
Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=27902
According to UnivDatos Market Insights (UMI)’
research report “Global Brain
Mapping Instruments Market”, the market is expected to witness robust
growth during the forecast period (2022-2028). This is
mainly due to the growing incidences of chronic diseases and rising investment in
clinical research.
Based on the product type, the market has been categorized
into functional magnetic resonance imaging (fMRI), computed axial tomography
(CAT), electroencephalography (EGG), magnetoencephalography, functional
near-infrared spectroscopy (fNIRS), positron emission tomography (PET), and
others. Among them, the electroencephalography segment is expected to have
significant growth in the market. The EEG measures the electrical activity of
the brain, and it is helpful in the diagnosis of many diseases including
seizures, sleep disorders, strokes, and others. The rising prevalence of
sleeping disorders coupled with the increasing number of stroke incidents are
attributed to the rising market the brain mapping instruments.
Unlock The Table of Content, And
Request a Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=27902
Based on the end-users, the market has been categorized
into hospitals, diagnostic centers, and others. Among them, the diagnostic
center’s segment is expected to have significant growth in the market. The increasing
number of brain diseases along with the integration of advanced technology in
the diagnostic centers responsible for the segmental growth in the brain
mapping instruments. According to the World Health Organization (WHO),
the global prevalence of epilepsy and multiple sclerosis was calculated at 50
million and 2.5 million respectively.
North America to witness extensive growth
For a better understanding of the market adoption
of the brain mapping instruments industry, the market is analyzed based on its
worldwide presence in the countries such as North America (U.S., Canada, Rest
of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of
Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of
World. North America constitutes a significant
brain mapping instruments market due to the increasing R&D activities and
frequent product launches in the region. Furthermore, the changing lifestyle in
the region is affecting the sleep cycle of the people and leads to the
shortening of sleep which ultimately cause different mental and neurological
disorders. For instance, as per the Canadian government, 1
in 2 adults have trouble going to sleep or staying asleep and 1 in 5 adults
does not find their sleep refreshing.
For More Informative Information, Please Visit
Us – https://univdatos.com/report/brain-mapping-instruments-market/
According to UnivDatos Market Insights (UMI)’,
the key players with a considerable market share in the brain mapping
instruments market are Medtronic, General Electric Company,
Koninklijke Philips N.V., Siemens Healthcare Private Limited, and Advanced
Brain Monitoring Inc.
“Global
Brain
Mapping Instruments Market” provides comprehensive qualitative and quantitative insights on
the industry potential, key factors impacting sales and purchase decisions,
hotspots, and opportunities available for the market players. Moreover, the
report also encompasses the key strategic imperatives for success for
competitors along with strategic factorial indexing measuring competitors’
capabilities on different parameters. This will help companies in the
formulation of go-to-market strategies and identifying the blue ocean for its
offerings.
Market Segmentation:
1. By
Product type (Functional Magnetic Resonance Imaging (fMRI),
Computed Axial Tomography (CAT), Electroencephalography (EGG),
Magnetoencephalography, Functional Near-Infrared Spectroscopy (fNIRS), Positron
Emission Tomography (PET), and Others)
2. By
End-users (Hospitals, Diagnostic Centers, and Others)
3. By
Region (North America, Europe, Asia-Pacific, Rest of
the World)
4.
By Company (Medtronic,
General Electric Company, Koninklijke Philips N.V., Siemens Healthcare Private
Limited, Advanced Brain Monitoring Inc., Natus Medical, Inc., Covidien PLC.,
Nihon Kohden Corporation, Canon Medical Systems Corp., and Cadwell Industries
Inc.)
Key
questions answered in the study:
1.
What are the current and future trends
of the global brain mapping instruments industry?
2.
How the industry has been evolving in
terms of product type and end-users?
3.
How the competition has been shaping
across the countries followed by their comparative factorial indexing?
4.
What are the key growth drivers and
challenges for the global brain mapping instruments industry?
5.
What is the customer orientation,
purchase behavior, and expectations from the global suppliers across various
region and countries?
Comments